Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Nessa Carey will lead the strategic development and implementation of the Entrepreneur in Residence (EiR) programme in Medical Sciences, laying the foundation of a world-class innovation support ecosystem capable of accelerating the translation of world-leading research into innovative therapies, business and commercial products.

Dr Nessa Carey and Royal Society (logo)

Managed by the MSD Translational Research Office (TRO), the scheme is designed to provide Oxford's research community with access to world-leading expertise and advice across multiple industry sectors in the following themes:

  • Development of compelling translational project/technology strategies
  • Navigating hurdles associated with commercialisation and spin-out, working alongside Oxford University Innovation
  • Sourcing and development of high quality bids for external funding streams

Dr Nessa Carey will bring broad, multi-stakeholder and non-sector specific strategic oversight to the programme. With experience of the biotechnology industry landscape, she has vast knowledge of business, IP and commercialisation strategies across biomedical modalities, and will work with Oxford's academic community to enrich innovative translational programmes with commercial context.

Dr Carey will also work with our Business Partnerships Office and Translational Research Office teams, as well as Oxford University Innovation, to facilitate the recruitment of ‘Experts’ with an in-depth sector-specific knowledge, which they will apply to research programmes to ensure routes to translation are optimised and potential hurdles identified early.

Find out more about the Entrepreneur in Residence scheme and Dr Nessa Carey

About the Royal Society Entrepreneur in Residence (EiR) Scheme

The Royal Society Entrepreneur in Residence (EiR) scheme, part of the Science, Industry and Translation programme, aims to increase the knowledge and awareness in UK universities of cutting edge industrial science, research and innovation. The successful applicants are funded to spend 20% of their time over two years with their host university and collaborators, sharing their experiences to help mentor and support students and academics. The scheme has now funded 49 placements in 29 universities across the UK since its inception in 2018.

Read more on the Royal Society website.

 

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.